Lieff Cabraser represented over seven hundred heart patients nationwide who were implanted with recalled Sprint Fidelis defibrillator leads manufactured by Medtronic Inc. Plaintiffs charge that Medtronic has misrepresented the safety of the Sprint Fidelis leads and a defect in the device triggered their receiving massive, unnecessary electrical shocks.
Medtronic Announces Settlement
On October 14, 2010, Medtronic announced that it had entered into an agreement to settle the litigation, subject to certain conditions. As of January 2013, the majority of claims had been paid through the Settlement Administration Process.
The Sprint Fidelis heart lead is a registered trademark of Medtronic, Inc. The use of this trademark is solely for product identification and informational purposes. Medtronic, Inc. is not affiliated with this website, and Medtronic, Inc. has no affiliation with Lieff Cabraser Heimann & Bernstein, LLP. Nothing on this site has been authorized or approved by Medtronic, Inc.